An increasing trend in the use of immunomodulators amongst IBD patients has been demonstrated in a recent paper assessing prescribing patterns amongst members of the Kaiser Permanente health care system in Northern California [ 53 ].
← all excerpts
The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?
1
—
—